Nightscout and CGM Blog
Nightscout and CGM guides, diab.ninja updates, and practical tips for people with type 1 diabetes, parents, and caregivers.
The blog covers Nightscout setup, glucose monitoring, xDrip+, Dexcom Share, FreeStyle Libre, AAPS and closed-loop integrations. We collect answers to common diab.ninja questions, explain new panel features, data safety, backups, glucose alerts, and everyday Nightscout use at home, at school, and with clinicians.
diab.ninja Nightscout hosting · Nightscout documentation
Latest posts
- CamAPS FX, Glooko, and Nightscout - Loop Data Setup
CamAPS FX manages therapy well, but its data access leaves much to be desired. Connecting CamAPS to Glooko, diab.ninja, and Nightscout gives you a much clearer view of glucose levels, meals, boluses, basal insulin, and the algorithm's activity throughout the day. Learn how to enable synchronization and confirm that your loop data is reaching the right destination.
- One Hundred Years After Insulin's Discovery - Why Are We Still Talking About "Better" Instead of "Cured"?
One hundred years after insulin's discovery, we are still waiting for a cure for type 1 diabetes. Are modern CGMs and pumps real progress?
- Ypsomed Is Gone, mylife Stays
Ypsomed is gone, mylife stays. What do the rebranding and Dexcom G7 mean for myLoop users? In this article, I clear up the main doubts.
- Dexcom Share vs Dexcom Clarity
Dexcom offers two services that can seem confusingly similar: Dexcom Share and Dexcom Clarity. Both work with sensor data, both require a Dexcom account, and both involve sharing data in some way. But they are fundamentally different tools built for different purposes. Mixing them up is one of the most common mistakes when setting up Nightscout.
- Medtronic Diabetes: finances versus patient reality
Diabetes revenue is up 15% in Q4, but does that mean better treatment? An analysis of Medtronic's report. Where is the money going? What about reimbursement?
- Dexcom Breaks Records: $4.66 Billion in Revenue in 2025
The company announced its full-year 2025 results. Revenue reached $4.662 billion, up 16% year over year. The fourth quarter alone brought in $1.260 billion, a 13% increase.
- The Diabetes Epidemic 2026 - Dexcom's Bleak Analysis
589 million people affected worldwide, over 3 million in Poland. The epidemic is accelerating. Dexcom knows it. Do we feel it?
- Is Dexcom winning the fight for type 2 diabetes? Stelo, Smart Basal, and a new strategy
Dexcom is going after type 2 diabetes. Stelo, Smart Basal, and a new strategy. Is this a real opportunity for millions of patients?
- Dexcom G8 - when?
Dexcom G8 with adaptive accuracy, 15-day wear time, and the prospect of ketone measurement. A 50% smaller sensor - launch expected in 2027/2028. This could be a real CGM breakthrough.
- Expensive design - who can afford to hide diabetes? (on class and access)
An insulin pump costs thousands of dollars, and pens are not cheap either. Is "pretty diabetes" a privilege of the middle and upper classes? An analysis of access, research quotes, and data from Canada and the US.
- An Insulin Pump with an MP3 Player? Bigfoot Biomedical's Strange Patent
Van Halen in an insulin pump? Bigfoot Biomedical patented a device that was meant to be both a pump and an MP3 player. Patent analysis, context, and criticism.
- Tandem t:slim X2 Pump - when a medical device looks like an iPhone
Tandem t:slim X2 looks like a smartphone: touchscreen, silver accents. Is this the right direction for insulin pumps? User impressions, research quotes, and the authors' own photos.